Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study).

Fiche publication

Date publication

juillet 2020

Journal

Gynecologic oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr KAMINSKY Marie-Christine

Tous les auteurs :
Robelin P, Tod M, Colomban O, Lachuer J, Ray-Coquard I, Rauglaudre G, Joly F, Chevalier-Place A, Combe P, Lortholary A, Hamizi S, Raban N, Ferron G, Meunier J, Berton-Rigaud D, Alexandre J, Kaminsky MC, Dubot C, Leary A, Malaurie E, You B

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32712155

Résumé

MicroRNAs (miRNAs) are promising biomarkers in ovarian cancer. Their kinetics during treatment might be useful for monitoring disease burden, and guiding treatments in patients treated with peri-operative chemotherapy and interval debulking surgery (IDS).